Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maike Schmidt

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Nature Communications|February 22, 2017
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in miceJanet Lau, Jeanne Cheung, Armando Navarro, et al.
Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
The Journal of Clinical Investigation|August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacyLeisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Breast Cancer Research : BCR|April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agentsChristy C Ong, Sarah Gierke, Cameron Pitt, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Nature Communications|February 22, 2017
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in miceJanet Lau, Jeanne Cheung, Armando Navarro, et al.
Cancer Research Communications|March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa ActivationJoel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
The Journal of Clinical Investigation|August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacyLeisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Breast Cancer Research : BCR|April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agentsChristy C Ong, Sarah Gierke, Cameron Pitt, et al.
Pageof 3